Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3763 3783
This examiner grants 73% of resolved cases
Justin L Zamory works in Tech Center 3700 and Art Unit 3763, having resolved 512 cases. The data shows an allowance rate of 72.9 percent. The median days to allowance is 1226, which provides a timeline for applicants seeking a patent in this unit. An interview lift of 17.4 percent suggests that direct communication with the examiner is a beneficial strategy for increasing the 72.9 percent allowance rate.
With 512 resolved cases, the examiner's statistics are well-defined. The 1226 median days to allowance and the 17.4 percent interview lift are key factors for practitioners to consider when developing their strategy for Art Unit 3763. The 72.9 percent allowance rate indicates a generally positive outlook for applications in Tech Center 3700. However, the 1226 days to allowance suggests that patience is required, and the 17.4 percent lift confirms that interviews are a useful tool for navigating this timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18501235 | MEDICAL DEVICES AND METHODS | Final Rejection | Boston Scientific Scimed, Inc. |
| 17286639 | ZERO-POINT ADJUSTMENT OF PREFILLED DRUG DELIVERY DEVICE | Final Rejection | Novo Nordisk A/S |
| 17299452 | CANNULAS WITH NON-CIRCULAR CROSS-SECTIONS, SYSTEMS, AND METHODS | Non-Final OA | INTUITIVE SURGICAL OPERATIONS, INC. |
| 17913291 | INJECTION SYSTEMS | Final Rejection | Mayo Foundation for Medical Education and Research |
| 17106697 | FLUID INJECTION SYSTEM HAVING VARIOUS SYSTEMS FOR CONTROLLING AN INJECTION PROCEDURE | Non-Final OA | BAYER HEALTHCARE LLC |
| 17938792 | DRUG DELIVERY DEVICE AND METHOD HAVING AN OCCLUDING MEMBER | Non-Final OA | WARSAW ORTHOPEDIC, INC. |
| 18443984 | HEMOSTASIS SEAL WITH LOW PASS-THROUGH FRICTION FORCE | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18787376 | INFUSION PUMP MONITORING | Non-Final OA | Welch Allyn, Inc. |
| 18398303 | MEDICAL INSTRUMENT WITH INTEGRAL NAVIGATION CONTROL FEATURES | Non-Final OA | Biosense Webster (Israel) Ltd. |
| 17452885 | MEDICAMENT INJECTION PEN FOR DISTINGUISHING BETWEEN PRIMING PEN EVENTS AND THERAPEUTIC PEN EVENTS | Non-Final OA | DexCom, Inc. |
| 18584035 | System for Infusion of Hazardous Drugs | Non-Final OA | Becton, Dickinson and Company |
| 17947342 | PUNCTURE NEEDLE, CATHETER ASSEMBLY, AND VASCULAR PUNCTURE SYSTEM | Non-Final OA | TERUMO KABUSHIKI KAISHA |
| 17685591 | TREATMENT DEVICE AND TREATMENT METHOD | Final Rejection | TERUMO KABUSHIKI KAISHA |
| 18523044 | LEAD SCREW WITHIN RESERVOIR | Non-Final OA | INSULET CORPORATION |
| 18340339 | WEARABLE DRUG DELIVERY DEVICE WITH INCORPORATED FILTRATION | Non-Final OA | INSULET CORPORATION |
| 17454770 | Distal Aspiration Catheter And Method | Final Rejection | MicroVention, Inc. |
| 17879070 | INFUSION DEVICE | Non-Final OA | SHL MEDICAL AG |
| 17379517 | MEDICAMENT DELIVERY DEVICE | Final Rejection | SHL MEDICAL AG |
| 18740388 | FORCE-LIMITING ACCESS SYSTEM AND METHOD OF USE | Non-Final OA | CALYXO, INC. |
| 17288147 | Needle Cover for a Medical Injection Device | Non-Final OA | Becton Dickinson France |
| 18097725 | SYSTEMS AND METHODS FOR DELAYED DRUG DELIVERY | Final Rejection | AMGEN INC. |
| 17054552 | RADIOEMBOLIZATION DELIVERY DEVICE | Final Rejection | Bard Peripheral Vascular, Inc. |
| 18797196 | Device to Control the Internal Body Pressure During Use of a Medical-Technical Pump | Non-Final OA | W.O.M. World of Medicine GmbH |
| 18648280 | KINETIC VACUUM TREATMENT DEVICES, SYSTEMS, AND METHODS | Non-Final OA | Inovio Pharmaceuticals, Inc. |
| 18136054 | IMPACT RESISTANT AND TAMPER EVIDENT SYSTEM FOR PREFILLED SYRINGE | Non-Final OA | FRESENIUS KABI USA, LLC |
| 18493269 | BREAST PUMPS | Final Rejection | Mother's Milk dba Spectra Baby USA |
| 17948271 | Refillable Implantable Device for Delivering a Drug Compound | Final Rejection | Celanese EVA Performance Polymers LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy